PTH and renal fibrosis: The renoprotective effect of the vitamin D receptor activators (VDRAs) on the development and progression of renal fibrosis could be mainly due to; (a) the role of vitamin D inhibiting the inflammatory process, (b) the vitamin D RAS downregulation, (c) the prevention of EMT, and (d) the reduction of PTH, among others (Figure 3).